Florida ranks second in growing new med device firms; AspenBio mulls name change;

 @FierceMedDev: Heart stent surgeries in China are now second only to the U.S., but more than half may be unnecessary. More | Follow @FierceMedDev

 @MarkHFierce: BSX CEO explains its repositioning is an attempt, in part, to respond to a rapidly changing healthcare industry. More | Follow @MarkHFierce

 @DamianFierce: Will GSK's new transparency pledge be a boon for CROs and drug developers? More | Follow @DamianFierce

> Inscopix and SRI International will collaborate on a new neuroscience imaging research and development effort focused on better understand how a normal brain functions compared to one with neurological and neuropsychiatric disorders. Item

> Lombard Medical Technologies in London, U.K., after feedback from the FDA, believes it is on track to receive PMA approval in the U.S. for Aorfix, its flexible stent graft for the endovascular repair of abdominal aortic aneurysms. Release

> U.K.-based Omega Diagnostics has signed an exclusive distribution deal with medical diagnostics firm SRL to market its food allergy test kits throughout India. Story

> Florida ranks second in the U.S. in growing new medical device firms, according to new research, and its companies in the space are expanding fast. Story

> Poly Medicure, an Indian company that makes catheters and surgical products, is planning to spend $18.6 million on expansions in the country. Item

> In vitro diagnostic player AspenBio Pharma ($APPY) is seeking shareholder approval to change its name to Venaxis. Release

Biotech News

 @FierceBiotech: How should India regulate its clinical trial industry? More | Follow @FierceBiotech

 @JohnCFierce: Zounds! Sloan-Kettering won't use Zaltrap (Sanofi/Regeneron) based on its cost and efficacy. Influential. More | Follow @JohnCFierce

 @RyanMFierce: New website crowdsources cancer therapies (some ideas more useful than others). More | Follow @RyanMFierce

> Aegerion shares surge on FDA review of rare cholesterol disease drug. Report

> Merck hooks late-stage infectious-disease portfolio with $571M deal. Article

> AstraZeneca turns to Beijing CRO as it scrambles to repair damaged pipeline. News

Pharma News

@FiercePharma: Profile of one man who's shaking up India's patent-protected drugmakers: Cipla founder YK Hamied. More | Follow @FiercePharma

> Izvestia: Abbott engineers Russian vaccines buyout. Story

> Top U.S. hospital won't use pricey Sanofi cancer drug. Article

> Cinven builds up Mercury with Amdipharm buy. Report

Biotech IT News

> Australia goes online for clinical trials awareness. Report

> Fight against 'unwarranted' drug patents goes online. More

> GSK to open clinical data vaults to scientists via website. Story

> Pharma group taps software to track adverse events in mobile apps. Article

CRO News

> How should India regulate its clinical trial industry? Item

> AstraZeneca taps China's Pharmaron to speed R&D. Report

> GSK's transparency pledge could be a boon to drug researchers. News

> Recipharm teams with Astimex on CDMO deal. Story

> Novasep pours $39M into new API plant. Article

Suggested Articles

A decade-long study found that patients with early breast cancer may be spared radiation procedures that span the whole breast.

A cell therapy for Parkinson’s disease starts out simple, but quickly gets complicated with the potential for immune responses and cancer mutations.

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.